Direct from Doug - cannot compete with Chinese rivals on price....

Direct from Doug - cannot compete with Chinese rivals on price. ViraDx will be withdrawn

I still don't get it. At the end of the day for Lumos, it is a staple revenue source for nearly a million a year. When they are talking cap raises to cover costs and expansion, that million at least covers his salary. lol I am curious to the burn it would take to make the product for that million in revenue.

Losing Viradx for the short term would still be a profit loss, so they must be projecting Febridx to exceed what Viradx was doing in the short term.